Evidence map›Paper›PMID 40064878›Full record

ArticleNature communications2025

Enantioselective construction of inherently chiral pillar[5]arenes via palladium-catalysed Suzuki-Miyaura cross-coupling.

Ting-Rui Luan, Che Sun, Yong-Le Tian, Yu-Kun Jiang, Long-Long Xi, Ren-Rong Liu

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Organocatalytic Enantioselective Divergent Synthesis of Pillar[5]Arenes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Ting-Rui Luan *College of Chemistry and Chemical Engineering, Qingdao University, Qingdao, China.
Che Sun *College of Chemistry and Chemical Engineering, Qingdao University, Qingdao, China.
Yong-Le TianCollege of Chemistry and Chemical Engineering, Qingdao University, Qingdao, China.
Yu-Kun JiangCollege of Chemistry and Chemical Engineering, Qingdao University, Qingdao, China.
Long-Long XiCollege of Chemistry and Chemical Engineering, Qingdao University, Qingdao, China. xill@qdu.edu.cn.ORCID http://orcid.org/0009-0009-6433-6156
Ren-Rong LiuCollege of Chemistry and Chemical Engineering, Qingdao University, Qingdao, China. renrongliu@qdu.edu.cn.ORCID http://orcid.org/0000-0002-6474-3909

Funding

National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) 22371152Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2023JQ006Taishan Scholar Foundation of Shandong Province tsqn201909096
6 · The paper itself

Abstract

Pillar[n]arenes have broad applications in biological medicine, materials science, and supramolecular gels. Notably, enantiopure pillar[5]arenes are valued for their roles in enantioselective host-guest recognition, chiral sensing, asymmetric catalysis, and related fields. Current methods for obtaining chiral pillar[n]arenes rely heavily on resolution agents or chiral HPLC resolution. However, the synthesis of these compounds via asymmetric catalysis remains challenging. In this study, we develop an asymmetric extended side-arm Suzuki-Miyaura cross-coupling strategy to construct inherently chiral pillar[5]arenes with excellent yields and high enantioselectivities using a palladium catalyst and a Sadphos ligand. The reaction scope extends beyond arylboronic acids to encompass 2-arylvinylboronic acids and other multi-OTf-substituted substrates, all efficiently producing the desired products. Further exploration of the synthetic applications, along with photophysical and chiroptical analyses, confirm the potential of these chiral pillar[5]arenes for diverse applications across multiple disciplines.

Identifiers

PMID40064878
PMCPMC11893803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.